Anders Lernevall
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Anders Lernevall has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Adam Jan Wronecki
Radiology Department, Aalborg Univeristy Hospital, Hobrovej 18-22, 9000 Aalborg, Denmark
1 shared publication - Elsebeth Lynge
Department of Public Health University of Copenhagen Copenhagen Denmark
1 shared publication - Ilse Vejborg
Department of Breast Examinations, University Hospital Herlev Gentofte, Hellerup, Denmark
1 shared publication - Martin Bak
Department of Pathology, Sydvestjysk Sygehus, Esbjerg, Denmark
1 shared publication - My von Euler-Chelpin
Department of Public Health, University of Copenhagen, Copenhagen, Denmark
1 shared publication - Niels Kroman
Department of Breast Surgery, Copenhagen University Hospital, Copenhagen, Denmark
1 shared publication
Latest Publications
- Open Access
- 28 December 2017
- Published by Springer Nature in BMC Cancer
- Vol. 17 (1) , 897
Outcome of breast cancer screening in Denmark
In Denmark, national roll-out of a population-based, screening mammography program took place in 2007–2010. We report on outcome of the first four biennial invitation rounds. Data on screening outcome were retrieved from the 2015 and 2016 national screening quality reports. We calculated coverage by examination; participation after invitation; detection-, interval cancer- and false-positive rates; cancer characteristics; sensitivity and specificity, for Denmark and for the five regions. At the national level coverage by examination remained at 75–77%; lower in the Capital Region than in the rest of Denmrk. Detection rate was slightly below 1% at first screen, 0.6% at subsequent screens, and one region had some fluctuation over time. Ductal carcinoma in situ (DCIS) constituted 13–14% of screen-detected cancers. In subsequent rounds, 80% of screen-detected invasive cancers were node negative and 40% ≤10 mm. False-positive rate was around 2%; higher for North Denmark Region than for the rest of Denmark. Three out of 10 breast cancers in screened women were diagnosed as interval cancers. High coverage by examination and low interval cancer rate are required for screening to decrease breast cancer mortality. Two pioneer local screening programs starting in the 1990s were followed by a decrease in breast cancer mortality of 22–25%. Coverage by examination and interval cancer rate of the national program were on the favorable side of values from the pioneer programs. It appears that the implementation of a national screening program in Denmark has been successful, though regional variations need further evaluation to assure optimization of the program.
- 28 December 2017
- Published by Springer Nature in BMC Cancer
- Vol. 17 (1) , 897
Open AccessOutcome of breast cancer screening in Denmark
In Denmark, national roll-out of a population-based, screening mammography program took place in 2007–2010. We report on outcome of the first four biennial invitation rounds. Data on screening outcome were retrieved from the 2015 and 2016 national screening quality reports. We calculated coverage by examination; participation after invitation; detection-, interval cancer- and false-positive rates; cancer characteristics; sensitivity and specificity, for Denmark and for the five regions. At the national level coverage by examination remained at 75–77%; lower in the Capital Region than in the rest of Denmrk. Detection rate was slightly below 1% at first screen, 0.6% at subsequent screens, and one region had some fluctuation over time. Ductal carcinoma in situ (DCIS) constituted 13–14% of screen-detected cancers. In subsequent rounds, 80% of screen-detected invasive cancers were node negative and 40% ≤10 mm. False-positive rate was around 2%; higher for North Denmark Region than for the rest of Denmark. Three out of 10 breast cancers in screened women were diagnosed as interval cancers. High coverage by examination and low interval cancer rate are required for screening to decrease breast cancer mortality. Two pioneer local screening programs starting in the 1990s were followed by a decrease in breast cancer mortality of 22–25%. Coverage by examination and interval cancer rate of the national program were on the favorable side of values from the pioneer programs. It appears that the implementation of a national screening program in Denmark has been successful, though regional variations need further evaluation to assure optimization of the program.